Ian R. McNicholl

Polypharmacy, Drug–Drug Interactions, and Potentially Inappropriate Medications in Older Adults with Human Immunodeficiency Virus Infection

Meredith Greene, Michael A. Steinman, Ian R. McNicholl et al. · Journal of the American Geriatrics Society · 2014 · 171 citations

Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy

S Viswanathan, Amy C. Justice, G. Caleb Alexander et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2015 · 99 citations

A Pharmacist‐Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older <scp>HIV</scp>‐Positive Patients

Ian R. McNicholl, Monica Gandhi, C. Bradley Hare et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2017 · 98 citations

Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial

Giuliano Rizzardini, Jean‐Michel Molina, Federico Pulido et al. · Infectious Diseases and Therapy · 2021 · 49 citations · Full text

Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trial

Giuliano Rizzardini, François Raffi, Federico Pulido et al. · The Lancet HIV · 2019 · 42 citations

Bone Disease, Bone Health, Treatment And Prevention +8